Reply to: Prior BRAF Inhibitor Exposure Is Not Enough to Define Resistance in the Phase I Mosperafenib Study
María Vieito, Elisa Fontana, Gabriel Schnetzler, David Dejardin et autres
0 citationsJournal of Clinical Oncology
Gabriel Schnetzler
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
121Publications signalées
664Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Melanoma and MAPK PathwaysColorectal Cancer Treatments and StudiesCancer Genomics and DiagnosticsProtein Kinase Regulation and GTPase SignalingCancer Immunotherapy and Biomarkers
Publications récentes
Supplementary Figure S1 from Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer
Martha L. Serrano‐Serrano, Christina Godfried Sie, Oliver Bechter, G. Pretelli et autres
0 citations
Figure 2 from Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer
Martha L. Serrano‐Serrano, Christina Godfried Sie, Oliver Bechter, G. Pretelli et autres
0 citations
Supplementary Figure S10 from Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer
Martha L. Serrano‐Serrano, Christina Godfried Sie, Oliver Bechter, G. Pretelli et autres
0 citations
Supplementary Figure S14 from Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer
Martha L. Serrano‐Serrano, Christina Godfried Sie, Oliver Bechter, G. Pretelli et autres
0 citations
Supplementary Figure S4 from Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer
Martha L. Serrano‐Serrano, Christina Godfried Sie, Oliver Bechter, G. Pretelli et autres
0 citations
Supplementary Figure S3 from Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer
Martha L. Serrano‐Serrano, Christina Godfried Sie, Oliver Bechter, G. Pretelli et autres
0 citations
Supplementary Figure S5 from Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer
Martha L. Serrano‐Serrano, Christina Godfried Sie, Oliver Bechter, G. Pretelli et autres
0 citations
Data from Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer
Martha L. Serrano‐Serrano, Christina Godfried Sie, Oliver Bechter, G. Pretelli et autres
0 citations
Figure 3 from Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer
Martha L. Serrano‐Serrano, Christina Godfried Sie, Oliver Bechter, G. Pretelli et autres
0 citations
Supplementary Figure S7 from Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer
Martha L. Serrano‐Serrano, Christina Godfried Sie, Oliver Bechter, G. Pretelli et autres
0 citations
Table 1 from Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer
Martha L. Serrano‐Serrano, Christina Godfried Sie, Oliver Bechter, G. Pretelli et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.